Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Masimo

Joe Kiani's Post-Masimo Playbook: Innovation Without Borders

For Kiani, entrepreneurship has never been merely about building companies; it has been about solving pressing problems with persistence and vision.

International Business Times

Blood oxygen tracking is set to return to Apple Watches in the US – but a new lawsuit could block it

Health company Masimo sues the US government for allowing the Apple Watch to regain its blood oxygen feature.

TechRadar

Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights

Apple Inc. (NASDAQ:AAPL) has reintroduced the blood-oxygen monitoring feature to its Apple Watch lineup after U.S. Customs and Border Protection approved imports of the devices — a decision that medical technology firm Masimo Corp. (NASDAQ:MASI) is now challenging in court.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

iOS 18.6.1 Restores Game-Changing Blood Oxygen Feature—But It Still Comes with New Hiccups

Apple restores blood oxygen monitoring on Apple Watch with iOS 18.6.1, but new glitches leave users weighing health benefits against fresh frustrations.

International Business Times UK

Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling

Apple Inc. (NASDAQ:AAPL) will introduce a redesigned Blood Oxygen feature for some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users through an iPhone and Apple Watch software update later on Thursday.

Benzinga

Apple brings back one of the Apple Watch’s main features after it disappeared

Blood oxygen monitoring had to be removed because of a patent issue

The Independent UK

Masimo Trying To Close In On Key Technical Measure

A Relative Strength Rating upgrade for Masimo shows improving technical performance. Will it continue?

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Joe Kiani is back: After being ousted from Masimo the billionaire has returned as CEO of Like Minded Labs

Also: All the news and watercooler chat from Fortune.

Fortune

How Immigrant Engineer and Entrepreneur Joe Kiani Reimagined Inclusion in Tech and Medicine

As founder of Masimo and the force behind Willow Laboratories, Kiani has contributed to life-saving innovations in patient monitoring and wellness.

International Business Times

Stocks Showing Improving Market Leadership: Masimo Earns 81 RS Rating

Masimo shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

Investors Business Daily

Stocks Flashing Renewed Technical Strength: Masimo

A Relative Strength Rating upgrade for Masimo shows improving technical performance.

Investors Business Daily

Masimo Clears Technical Benchmark, Hitting 80-Plus RS Rating

A Relative Strength Rating upgrade for Masimo shows improving technical performance.

Investors Business Daily

Masimo Earns RS Rating Upgrade

Masimo shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Stocks Showing Improved Relative Strength: Masimo

A Relative Strength Rating upgrade for Masimo shows improving technical performance. Will it continue?

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

What Hi-Fi?

Bowers & Wilkins finds a new home, what to expect from High End Munich, a new B&O speaker and more

Our experts detail the top hi-fi and home cinema highlights from last week

TechRadar

Top medical device maker Masimo confirms cyberattack, says products may be delayed

No confirmation if it was a ransomware attack yet, but parts of Masimo infrastructure were shut down to contain the incident.

What Hi-Fi?

3 key reasons I’m optimistic that Harman ownership will be good for Bowers & Wilkins

B&W is not struggling, but being owned by an audio, not medical, company is a healthy development

What Hi-Fi?

Harman is buying Bowers & Wilkins, Marantz and Denon as Masimo sells its consumer audio business

The $350m transaction is expected to close by the end of the year

Get all your
news in one place.

100’s of premium titles.
One news app.

What Hi-Fi?

Winners of the public vote for Best Sound at the Australian Hi-Fi Show 2025

You voted, we counted: here are the top four rooms voted to have the best sound, for you, at the Sydney Show

Investors Business Daily

Stocks Showing Rising Market Leadership: Masimo Earns 88 RS Rating

A Relative Strength Rating upgrade for Masimo shows improving technical performance.

Tom’s Guide

Apple Watch escapes U.S. import ban after court victory in patent case

There will be no repeat of last year’s wearable ban after all

Investors Business Daily

Masimo Joins Elite Club Of Stocks With RS Ratings Over 90

Masimo sees its Relative Strength Rating enter the elite 90-plus level.

Investors Business Daily

Masimo Makes A Bullish Post-Earnings Move. Why One Analyst Is Cautious.

Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could squeeze profits.

TechRadar

Apple Watch Blood Oxygen feature isn't returning anytime soon as company fails in creative court bid to get ban lifted

An Apple Watch court ruling has failed to give Apple the means it needed to try and overturn the Apple Watch Blood Oxygen ban in the US.

Tom’s Guide

Apple wins patent lawsuit (and $250) from Masimo — but it won’t affect Apple Watch’s MIA blood oxygen feature

Apple wins a small patent infringement case against medical device maker Masimo, but blood oxygen measurement on new Apple Watch is unaffected

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations